Sumitomo Pharma America, Inc.

Sumitomo Pharma America and Pfizer Oncology are working together to redefine care for millions of patients living with cancer, and aspire to provide medicines that can improve lives and change treatment paradigms. By combining Sumitomo Pharma America’s commitment to purpose-driven science with Pfizer’s deep heritage and leadership in oncology, we are uniquely positioned to provide innovative treatments that fulfill significant unmet needs and make a meaningful difference in people’s lives.